Sign inJoin waitlistJoin the waitlist

Tim Fischell

Program Director, Interventional Cardiology Fellowship Program · Michigan State Univ Coll Osteo Med

Credentials: · · · · · ·

History

Interventional Cardiology Fellowship · Michigan State Univ Coll Osteo Med
Present
Western Michigan University Homer Stryker MD School of Medicine
Present
Michigan State Univ Coll Osteo Med
Present

Stanford Health Care
1987–1989
Interventional Cardiology
The Medical Center
1986–1987
Cardiovascular Disease
The Medical Center
1984–1986
Internal Medicine
Massachusetts General Hospital
1981–1984
Weill Cornell Medicine
1977–1981

Research

Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis
Circulation · 2004 · 425 citations
Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. A quantitative arteriographic analysis
Circulation · 1988 · First of 4 authors · 219 citations
Transesophageal two-dimensional echocardiography and color Doppler flow velocity mapping in the evaluation of cardiac valve prostheses
Circulation · 1988 · 152 citations

AC
Andrew Carter
10 papers
RV
Renu Virmani
8 papers
MF
Malcolm Foster
7 papers · 3 as a fellow
David Kandzari
6 papers
Frank Saltiel
6 papers · 1 as a fellow
Adnan Kassier
5 papers · 5 as a fellow
DH
David Holmes
5 papers
MS
Michael Stadius
5 papers
Michael Weber
5 papers
Jeffrey Moses
4 papers
Jeffrey Popma
4 papers
KK
Kameel Kassab
4 papers · 4 as a fellow

Grants

Commercial Readiness of a Catheter for Complex Percutaneous Coronary Intervention
National Heart, Lung, and Blood Institute · SB1
Contact PI · $496.4K · Vantis Vascular Inc
2026–2027
Catheter for Complex Percutaneous Coronary Intervention
National Heart, Lung, and Blood Institute · R44
Contact PI · $4.8M · Vantis Vascular Inc
2020–2027
Catheter for Complex Percutaneous Coronary Intervention
National Heart, Lung, and Blood Institute · R43
Contact PI · $298.2K · Vantis Vascular Inc
2020–2021